Activity value 76china Buyer&Supplier,Last transaction date:
2026-05-23
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for ruyuan hec pharm co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 8 transactions, with a transaction quantity of 198.95 and a transaction weight of 83.
YearTransactionsQuantityWeight
202520583.3439.95
20268198.9583
Bill of lading data
<
1/15
>
Trade date
2026/05/23
B/L No.
——
Suppliers
ruyuan hec pharm co.ltd.
Buyers
advanced chemical industries plc.
POLs
——
PODs
dhaka
Supply area
China
Purchas area
Bangladesh
Weight
3kg
Amount
1410
Hs code
29349990
Product tags
rivaroxaban
Product description
RIVAROXABAN
Expand
Trade date
2026/04/20
B/L No.
108167083840
Suppliers
ruyuan hec pharm co.ltd.
Buyers
công ty cổ phần dược phẩm ampharco usa
Product description
LINAGLIPTIN. Tiêu chuẩn In-house. Nguyên liệu để nghiên cứu sản xuất thuốc. Lô LGLT- 202510104. NSX 13/10/2025. HD 12/10/2028. Nhà SX: Ruyuan Hec Pharm Co., Ltd. Hàng mới 100%.
Expand
Trade date
2026/02/05
B/L No.
107961857840
Suppliers
ruyuan hec pharm co.ltd.
Buyers
công ty trách nhiệm hữu hạn sinh dược phẩm hera
Product description
Daclatasvir Dihydrochloride, nguyên liệu là dược chất, BTP để sản xuất thuốc, có STT 261 thuộc DM7 của TT 09/2024/TT-BYT, BN: S109A-202503701, NSX: 19/03/2025, HSD: 18/03/2029, mới100%
Expand
Product description
Nguyên liệu làm thuốc: Sitagliptin Phosphate Monohydrate. Tiêu chuẩn USP2025. Lot: STPE-202508601, Nsx 08/2025 - Date 08/2028. Ruyuan Hec Pharm Co., Ltd - China sản xuất. Visa thuốc số VD-32790-19
Expand
Product description
Sofosbuvir, Nguyên liệu là dược chất, BTP để sản xuất thuốc, có STT 841 thuộc DM7 của TT 09/2024, BN: S104A-202508601-1, NSX: 20/08/2025, HSD: 19/08/2029, mới100%; ĐG:40KGS/2DRUMS
Expand
Trade date
2025/11/13
B/L No.
107702799630
Suppliers
ruyuan hec pharm co.ltd.
Buyers
công ty cổ phần dược vật tư y tế hải dương
Product description
Sitagliptin Phosphat Monohydrat.Tiêu chuẩn USP-NF 2024. Nguyên liệu để sản xuất thuốc . Lô STPE-202506601. NSX:12/06/2025. HD:11/06/2028. Nhà SX:RUYUAN HEC PHARM CO.,LTD. Hàng mới 100%.
Expand
Trade date
2025/11/13
B/L No.
107704059040
Suppliers
ruyuan hec pharm co.ltd.
Buyers
công ty cổ phần dược trang thiết bị y tế bình định bidiphar
ruyuan hec pharm co.ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as sulpiride,sitagliptin phosphate,phosphoric acid.
According to the 52wmb.com global trade database, as of 2026-05-23, the company has completed 133 international trades,
with its main trading regions covering vietnam,bangladesh,pakistan etc.
The core products include HS29351000,HS29335990,HS29349990 etc,
often transported via hangzhou,port hangzhou cn, port other cn etc,
and its main trading partners are công ty liên doanh meyer bpc,meyer bpc joint venture co,chi nhánh công ty tnhh glandcore.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on ruyuan hec pharm co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.